Results 191 to 200 of about 9,520,801 (360)
Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire
Anthony T. Tan +13 more
openalex +2 more sources
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL) [PDF]
Hanne Vibeke Marquart +4 more
openalex +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Unveiling the B-cell conundrum in in-stent restenosis. [PDF]
Deng Z, Ma B.
europepmc +1 more source
Targeting B-cells in lupus nephritis: should cautious optimism remain? [PDF]
Brad H. Rovin
openalex +1 more source
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL). [PDF]
Górniak P +11 more
europepmc +1 more source

